| Ms Leslie A Murtagh, APRN | |
|
350 W A St, Suite 204, Casper, WY 82601-1860 | |
| (307) 472-9890 | |
| (307) 472-9891 |
| Full Name | Ms Leslie A Murtagh |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent |
| Location | 350 W A St, Casper, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811198609 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0807X | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent | 19778.237 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Leslie A Murtagh, APRN 1821 Brighton St, Casper, WY 82609-3809 Ph: (307) 472-9890 | Ms Leslie A Murtagh, APRN 350 W A St, Suite 204, Casper, WY 82601-1860 Ph: (307) 472-9890 |
News Archive
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
Elderly people with visual disorders that are left untreated are significantly more likely to develop Alzheimer's disease - the most common form of dementia, according to a University of Michigan Health System study.
Medicare beneficiaries in some parts of the United States appear more likely to receive carotid endarterectomy, a surgical procedure to clear blockages in the artery supplying blood to the head, whereas those in other regions more often receive stents for the same condition, according to a report in the July 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Tibet Pharmaceuticals, Inc., an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, announces the availability of an updated online Investor Fact Sheet.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
› Verified 1 days ago
Mrs. Raegan Layher Kartupelis, PMHNP-BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 6631 E 2nd St, Casper, WY 82609 Phone: 307-268-9904 | |
Ms. Michele Marie Powell-braman, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4140 S Poplar St, Casper, WY 82601 Phone: 307-235-4143 | |
Crystal Lynn Bardgett, DNP, APRN Clinical Nurse Specialist Medicare: May Accept Medicare Assignments Practice Location: 1743 E Yellowstone Hwy, Casper, WY 82601 Phone: 307-262-8600 Fax: 307-205-0494 |